This inventor holds 1 USPTO granted patent. Top assignee: Dinona Inc.. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Young Hoon Lim: Innovator in Cancer Treatment
Introduction
Young Hoon Lim is a notable inventor based in Nonsan, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of antibodies.
Latest Patents
Young Hoon Lim holds a patent for an antibody binding specifically to CD66c and its use in treating cancer. This invention focuses on an anti-CD66c antibody that can induce T-cell activation or a humoral immune response. The patent also includes a nucleic acid molecule encoding the antibody or its antigen-binding fragment, a vector containing the nucleic acid molecule, and a host cell. This invention aims to alleviate, prevent, treat, or diagnose diseases related to CD66c.
Career Highlights
Young Hoon Lim is associated with Dinona Inc., where he continues to work on groundbreaking research in the field of immunotherapy. His dedication to advancing cancer treatment has positioned him as a key figure in the industry.
Collaborations
He collaborates with talented individuals such as Sangsoon Yoon and Kwon Pyo Hong, contributing to a dynamic research environment focused on innovative solutions for cancer treatment.
Conclusion
Young Hoon Lim's work exemplifies the impact of innovative research in the medical field, particularly in cancer therapy. His contributions through patents and collaborations highlight the importance of continued advancements in healthcare.